Genomic Tumor Board (GTB) Sessions

The MCGI Genomic Tumor Board meetings convene by video-teleconference (VTC), allowing providers from across the State of Maine to access this educational activity without need for travel. VTC access information is provided in an invite to MCGI-study enrolled clinicians. GTB meetings are 30 minutes to 1 hour in length. 

Due to the virtual format of the sessions, physician sign-in for CME credit is recorded as a screen-shot image of the participants list within the VTC software, or on a hand copy sign-in sheet for in-person attendees at MCGI study sites.
    
CME evaluations are sent electronically at the end of the year-long GTB session series to signed-in attendees. Upon completing and submitting the evaluation, attendees are awarded up to the maximum CME credits for which they are eligible.

Clinicians interested in attending may contact us at mcgi@jax.org to be added to the invitation list.

All sessions convene via video-teleconference (VTC) in U.S. Eastern Time.  

JANUARY

• Wednesday, January 6, at 7:45 a.m., with SMHC
• Wednesday, January 13, at 12:30 p.m., with Pen Bay
• Tuesday, January 19, at 12:15 p.m., with HACCC
• Thursday, January 21, at 4:00 p.m., with Northern Light
• Wednesday, January 27, at 12:00 p.m., with MMP Oncology
• Friday, January 29, at 9:00 a.m., with Gynecologic Oncology

FEBRUARY

• Tuesday, February 2, at 9:00 a.m., with Neuro-Oncology
• Thursday, February 4, at 12:00 p.m., with Mercy
• Wednesday, February 10, at 12:30 p.m., with Pen Bay
• Thursday, February 11, at 11:00 a.m., with Pediatric Oncology
• Tuesday, February 16, at 12:15 p.m., with HACCC
• Thursday, February 18, at 4:00 p.m., with Northern Light
• Wednesday, February 24, at 12:00 p.m., with MMP Oncology

MARCH

• Wednesday, March 3, at 7:45 a.m., with SMHC
• Wednesday, March 10, at 12:30 p.m., with Pen Bay
• Tuesday, March 16, at 12:15 p.m., with HACCC
• Thursday, March 18, at 4:00 p.m., with Northern Light
• Wednesday, March 24, at 12:00 p.m., with MMP Oncology

APRIL

• Thursday, April 1, at 12:00 p.m., with Mercy
• Thursday, April 8, at 11:00 a.m., with Pediatric Oncology
• Wednesday, April 14, at 12:30 p.m., with Pen Bay
• Thursday, April 15, at 4:00 p.m., with Northern Light
• Tuesday, April 20, at 9:00 a.m., with Neuro-Oncology
• Tuesday, April 20, at 12:15 p.m., with HACCC
• Wednesday, April 28, at 12:00 p.m., with MMP Oncology
• Friday, April 30, at 9:00 a.m., with Gynecologic Oncology

MAY

• Wednesday, May 5, at 7:45 a.m., with SMHC
• Wednesday, May 12, at 12:30 p.m., with Pen Bay
• Tuesday, May 18, at 12:15 p.m., with HACCC
• Thursday, May 20, at 4:00 p.m., with Northern Light
• Wednesday, May 26, at 12:00 p.m., with MMP Oncology

JUNE

• Tuesday, June 1, at 9:00 a.m., with Neuro-Oncology
• Thursday, June 3, at 12:00 p.m., with Mercy
• Wednesday, June 9, at 12:30 p.m., with Pen Bay
• Thursday, June 10, at 11:00 a.m., with Pediatric Oncology
• Tuesday, June 15, at 12:15 p.m., with HACCC
• Thursday, June 17, at 4:00 p.m., with Northern Light
• Wednesday, June 23, at 12:00 p.m., with MMP Oncology

JULY

• Wednesday, July 7, at 7:45 a.m., with SMHC
• Wednesday, July 14, at 12:30 p.m., with Pen Bay
• Thursday, July 15, at 4:00 p.m., with Northern Light
• Tuesday, July 20, at 12:15 p.m., with HACCC
• Wednesday, July 28, at 12:00 p.m., with MMP Oncology
• Friday, July 30, at 9:00 a.m., with Gynecologic Oncology

AUGUST

• Tuesday, August 3, at 9:00 a.m., with Neuro-Oncology
• Thursday, August 5, at 12:00 p.m., with Mercy
• Wednesday, August 11, at 12:30 p.m., with Pen Bay
• Thursday, August 12, at 11:00 a.m., with Pediatric Oncology
• Tuesday, August 17, at 12:15 p.m., with HACCC
• Thursday, August 19, at 4:00 p.m., with Northern Light
• Wednesday, August 25, at 12:00 p.m., with MMP Oncology

SEPTEMBER

• Wednesday, September 1, at 7:45 a.m., with SMHC
• Wednesday, September 8, at 12:30 p.m., with Pen Bay
• Thursday, September 16, at 4:00 p.m., with Northern Light
• Tuesday, September 21, at 12:15 p.m., with HACCC
• Wednesday, September 22, at 12:00 p.m., with MMP Oncology

OCTOBER

• Tuesday, October 5, at 9:00 a.m., with Neuro-Oncology
• Thursday, October 7, at 12:00 p.m., with Mercy
• Wednesday, October 13, at 12:30 p.m., with Pen Bay
• Thursday, October 14, at 11:00 a.m., with Pediatric Oncology
• Tuesday, October 19, at 12:15 p.m., with HACCC
• Thursday, October 21, at 4:00 p.m., with Northern Light
• Wednesday, October 27, at 12:00 p.m., with MMP Oncology
• Friday, October 29, at 9:00 a.m., with Gynecologic Oncology

NOVEMBER

• Wednesday, November 3, at 7:45 a.m., with SMHC
• Wednesday, November 10, at 12:30 p.m., with Pen Bay
• Tuesday, November 16, at 12:15 p.m., with HACCC
• Thursday, November 18, at 4:00 p.m., with Northern Light

DECEMBER

• Wednesday, December 1, at 12:00 p.m., with MMP Oncology
• Thursday, December 2, at 12:00 p.m., with Mercy
• Wednesday, December 8, at 12:30 p.m., with Pen Bay
• Thursday, December 9, at 11:00 a.m., with Pediatric Oncology
• Thursday, December 16, at 4:00 p.m., with Northern Light
• Tuesday, December 21, at 12:15 p.m., with HACCC
• Wednesday, December 22, at 12:00 p.m., with MMP Oncology

The MCGI GTB sessions feature the presentation of one or more case vignettes, drawn from actual, in-treatment patients who have consented to participate in the MCGI study. Review of all clinical information is done in a coded-manner. Protected health information (PHI) is not disclosed in the GTB meetings.  

Information reviewed includes the patient’s diagnosis, pertinent history of illness, previous treatment approaches, and results from MCGI study-related genomic cancer testing. At the discretion of the presenter, pathology findings and other information about the case pertinent to clinical decision making may also be discussed.  

Commentary and discussion centers on genomic variant interpretation, pathology, oncology, and community knowledge of similar cases. A summary of the discussion of each case is recorded as part of the session's official minutes.

After attendance, participants should be able to:

• Recognize how gene variants are determined, catalogued, curated, and made meaningful to clinicians;
• Recognize the application of precision medicine in clinical care;
• Assess the use of precision medicine in practice by appraising the benefits and limitations of precision medicine for an individual patient case; and
• Formulate potential treatment approaches based on interpretation of information presented about the case in the genomic tumor board format.

 

Certified CME Activity 

Target Audience:

Maine clinicians practicing oncology, involved in cancer patient care and/or cancer research, who have enrolled in the MCGI study.

Accreditation and Joint Sponsorship:

The 2021 MCGI GTB sessions are a certified Continuing Medical Education (CME) activity sponsored by the Maine Medical Education Trust (MMET). 

American Medical Association (AMA) Designation Statement: The Maine Medical Education Trust designates this live activity for a maximum of 70 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Committee on Continuing Medical Education and Accreditation (CCMEA) Accreditation Statement: Maine Medical Education Trust is accredited by the Maine Medical Association's Committee on Continuing Medical Education and Accreditation to provide continuing medical education (CME) to practicing physicians.

Joint Sponsorship: This activity has been planned and implemented in accordance with the Essentials and Standards of the Maine Medical Association's Committee on Continuing Medical Education and Accreditation through the partnership of Maine Medical Education Trust and The Jackson Laboratory.

The Maine Medical Education Trust is accredited by the Maine Medical Association to provide CME activities for physicians.

 

Certified American Board of Pediatrics (ABP) Maintenance of Certification (MOC) Activity 

MOC Credit:

In addition to CME credits, Maintenance of Certification (MOC) for the American Board of Pediatrics (ABP) Part 2 credits is offered for select Pediatric Genomic Tumor Boards. 

Target Audience:

Maine clinicians practicing pediatric oncology, involved in cancer patient care and/or cancer research who have enrolled in the MCGI study.

Accreditation and Joint Sponsorship:

The 2021 MCGI Pediatric GTB sessions are a certified ABP MOC Activity Sponsored by the Maine Medical Education Trust. 

MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to AACME for the purpose of granting ABP MOC credit.

CCMEA Accreditation Statement: Maine Medical Education Trust is accredited by the Maine Medical Association's Committee on Continuing Medical Education and Accreditation to provide continuing medical education (CME) to practicing physicians.

Joint Sponsorship: This activity has been planned and implemented in accordance with the Essentials and Standards of the Maine Medical Association's Committee on Continuing Medical Education and Accreditation through the partnership of Maine Medical Education Trust and The Jackson Laboratory.

The Maine Medical Education Trust is accredited by the Maine Medical Association to provide CME activities for physicians.

 

Claiming MOC and CME Credit

Claiming ABP MOC Credit:
At the end of the 2021 GTB series, an electronic evaluation will be sent to participants who logged into the VTC, signed an in-person hard copy attendance sheet, and/or made themselves known on the audio teleconference line, as recorded in the session minutes. 

ABP MOC credit is MOC Part 2 Credit(s) TM and is intended for physicians and will be uploaded to the ABP records via the PARS network for any eligible clinician who completes the requirements and the authorization form.

Participants may claim credit for each pediatric session they attend. A series certificate is provided after the end of the calendar year totaling all credits received for a participant for the 2021 series. 
 
Claiming CME Credit:
At the end of the 2021 GTB series an electronic evaluation will be sent to participants who logged into the VTC, signed an in-person hard copy attendance sheet and/or made themselves known on the audio teleconference line. 

CME credit is AMA PRA Category 1 Credit(s) TM and is intended for physicians; however, the MCGI GTB session series will offers CME credit documentation to any participant claiming it who has completes the session evaluation at the series' conclusion at the end of the calendar year. For non-clinician participants, it is their responsibility to determine if their respective licensure agency accepts these credits. 

Participants may claim credit for each session they attend. A series certificate is provided after the end of the calendar year totaling all credits received for a participant for the 2021 series. 

 

Disclosures 

There is no commercial support for the Maine Cancer Genomics Initiative (MCGI) or its educational activities. MCGI is a program of The Jackson Laboratory funded through a generous grant from the Harold Alfond® Foundation.
 
The Jackson Laboratory (www.jax.org) is an independent, 501(c)3 nonprofit biomedical research institution with more than 2,200 employees. Headquartered in Bar Harbor, Maine, it has a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn. Its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
 
Founded in 1950, Harold Alfond® Foundation furthers the philanthropic legacy of Harold Alfond, the founder of Dexter Shoe Company and a longtime supporter of Maine communities in which he and his family worked and resided. Harold Alfond awarded matching challenge grants to organizations to build community partnerships and to inspire and leverage additional giving by others. He ensured his philanthropy would live on by committing nearly all of his wealth to the Foundation, which continues to support charitable causes in the State of Maine.
 
Americans with Disabilities Act (ADA):
 
Services for the Disabled. If special arrangements are required for an individual with a disability to attend this course please contact Jennifer Bourne at The Jackson Laboratory, at 207-288-6113 or jennifer.bourne@jax.org.